The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Anti-Infectives Market Research Report 2025
Synopsis
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Infectives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infectives.
Report Scope
The Anti-Infectives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Infectives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Infectives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astra Zeneca plc
Johnson & Johnson
Glaxo SmithKline plc
Novartis
Pfizer
Wockhardt ltd
Roche
Sanofi
Merck
Segment by Type
Antibacterial
Antiviral
Antifungal
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Infectives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-Infectives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-Infectives.
Report Scope
The Anti-Infectives market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anti-Infectives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-Infectives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astra Zeneca plc
Johnson & Johnson
Glaxo SmithKline plc
Novartis
Pfizer
Wockhardt ltd
Roche
Sanofi
Merck
Segment by Type
Antibacterial
Antiviral
Antifungal
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Mail Order Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Anti-Infectives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Anti-Infectives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Anti-Infectives Market Overview
1.1 Product Overview and Scope of Anti-Infectives
1.2 Anti-Infectives Segment by Type
1.2.1 Global Anti-Infectives Market Value Comparison by Type (2024-2030)
1.2.2 Antibacterial
1.2.3 Antiviral
1.2.4 Antifungal
1.3 Anti-Infectives Segment by Application
1.3.1 Global Anti-Infectives Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Mail Order Pharmacies
1.4 Global Anti-Infectives Market Size Estimates and Forecasts
1.4.1 Global Anti-Infectives Revenue 2019-2030
1.4.2 Global Anti-Infectives Sales 2019-2030
1.4.3 Global Anti-Infectives Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anti-Infectives Market Competition by Manufacturers
2.1 Global Anti-Infectives Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anti-Infectives Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anti-Infectives Average Price by Manufacturers (2019-2024)
2.4 Global Anti-Infectives Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti-Infectives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti-Infectives, Product Type & Application
2.7 Anti-Infectives Market Competitive Situation and Trends
2.7.1 Anti-Infectives Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anti-Infectives Players Market Share by Revenue
2.7.3 Global Anti-Infectives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Infectives Retrospective Market Scenario by Region
3.1 Global Anti-Infectives Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anti-Infectives Global Anti-Infectives Sales by Region: 2019-2030
3.2.1 Global Anti-Infectives Sales by Region: 2019-2024
3.2.2 Global Anti-Infectives Sales by Region: 2025-2030
3.3 Global Anti-Infectives Global Anti-Infectives Revenue by Region: 2019-2030
3.3.1 Global Anti-Infectives Revenue by Region: 2019-2024
3.3.2 Global Anti-Infectives Revenue by Region: 2025-2030
3.4 North America Anti-Infectives Market Facts & Figures by Country
3.4.1 North America Anti-Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anti-Infectives Sales by Country (2019-2030)
3.4.3 North America Anti-Infectives Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti-Infectives Market Facts & Figures by Country
3.5.1 Europe Anti-Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anti-Infectives Sales by Country (2019-2030)
3.5.3 Europe Anti-Infectives Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti-Infectives Market Facts & Figures by Country
3.6.1 Asia Pacific Anti-Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anti-Infectives Sales by Country (2019-2030)
3.6.3 Asia Pacific Anti-Infectives Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti-Infectives Market Facts & Figures by Country
3.7.1 Latin America Anti-Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anti-Infectives Sales by Country (2019-2030)
3.7.3 Latin America Anti-Infectives Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti-Infectives Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti-Infectives Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anti-Infectives Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anti-Infectives Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti-Infectives Sales by Type (2019-2030)
4.1.1 Global Anti-Infectives Sales by Type (2019-2024)
4.1.2 Global Anti-Infectives Sales by Type (2025-2030)
4.1.3 Global Anti-Infectives Sales Market Share by Type (2019-2030)
4.2 Global Anti-Infectives Revenue by Type (2019-2030)
4.2.1 Global Anti-Infectives Revenue by Type (2019-2024)
4.2.2 Global Anti-Infectives Revenue by Type (2025-2030)
4.2.3 Global Anti-Infectives Revenue Market Share by Type (2019-2030)
4.3 Global Anti-Infectives Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anti-Infectives Sales by Application (2019-2030)
5.1.1 Global Anti-Infectives Sales by Application (2019-2024)
5.1.2 Global Anti-Infectives Sales by Application (2025-2030)
5.1.3 Global Anti-Infectives Sales Market Share by Application (2019-2030)
5.2 Global Anti-Infectives Revenue by Application (2019-2030)
5.2.1 Global Anti-Infectives Revenue by Application (2019-2024)
5.2.2 Global Anti-Infectives Revenue by Application (2025-2030)
5.2.3 Global Anti-Infectives Revenue Market Share by Application (2019-2030)
5.3 Global Anti-Infectives Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astra Zeneca plc
6.1.1 Astra Zeneca plc Corporation Information
6.1.2 Astra Zeneca plc Description and Business Overview
6.1.3 Astra Zeneca plc Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astra Zeneca plc Anti-Infectives Product Portfolio
6.1.5 Astra Zeneca plc Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Johnson & Johnson Anti-Infectives Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Glaxo SmithKline plc
6.3.1 Glaxo SmithKline plc Corporation Information
6.3.2 Glaxo SmithKline plc Description and Business Overview
6.3.3 Glaxo SmithKline plc Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Glaxo SmithKline plc Anti-Infectives Product Portfolio
6.3.5 Glaxo SmithKline plc Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis Anti-Infectives Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pfizer Anti-Infectives Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Wockhardt ltd
6.6.1 Wockhardt ltd Corporation Information
6.6.2 Wockhardt ltd Description and Business Overview
6.6.3 Wockhardt ltd Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Wockhardt ltd Anti-Infectives Product Portfolio
6.6.5 Wockhardt ltd Recent Developments/Updates
6.7 Roche
6.6.1 Roche Corporation Information
6.6.2 Roche Description and Business Overview
6.6.3 Roche Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Anti-Infectives Product Portfolio
6.7.5 Roche Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sanofi Anti-Infectives Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Anti-Infectives Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Merck Anti-Infectives Product Portfolio
6.9.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti-Infectives Industry Chain Analysis
7.2 Anti-Infectives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti-Infectives Production Mode & Process
7.4 Anti-Infectives Sales and Marketing
7.4.1 Anti-Infectives Sales Channels
7.4.2 Anti-Infectives Distributors
7.5 Anti-Infectives Customers
8 Anti-Infectives Market Dynamics
8.1 Anti-Infectives Industry Trends
8.2 Anti-Infectives Market Drivers
8.3 Anti-Infectives Market Challenges
8.4 Anti-Infectives Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
